Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Menlo Ventures continues scaling focus on tech-enabled bio 

Menlo is looking to invest in generative AI for drug design and problem-solvers for gene editing — and to grow its healthcare team

July 11, 2023 9:30 PM UTC

Menlo Ventures is continuing to expand its healthcare focus and betting big on generative AI, where it sees data specialization, not size, as the key to success.

Menlo’s Greg Yap told BioCentury the VC is “trying to scale up our investments in the area of technology-enabled bio” by dedicating more resources to building its healthcare team and portfolio, and looking for “the relatively small number of places” where a platform technology can overcome a challenge blocking therapeutic progress...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article